These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 35834898)

  • 1. Decavanadate and metformin-decavanadate effects in human melanoma cells.
    De Sousa-Coelho AL; Aureliano M; Fraqueza G; Serrão G; Gonçalves J; Sánchez-Lombardo I; Link W; Ferreira BI
    J Inorg Biochem; 2022 Oct; 235():111915. PubMed ID: 35834898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sarcoplasmic reticulum calcium ATPase interactions with decaniobate, decavanadate, vanadate, tungstate and molybdate.
    Fraqueza G; Ohlin CA; Casey WH; Aureliano M
    J Inorg Biochem; 2012 Feb; 107(1):82-9. PubMed ID: 22178669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decavanadate, decaniobate, tungstate and molybdate interactions with sarcoplasmic reticulum Ca(2+)-ATPase: quercetin prevents cysteine oxidation by vanadate but does not reverse ATPase inhibition.
    Fraqueza G; Batista de Carvalho LA; Marques MP; Maia L; Ohlin CA; Casey WH; Aureliano M
    Dalton Trans; 2012 Nov; 41(41):12749-58. PubMed ID: 22968713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of vanadate oligomers with sarcoplasmic reticulum Ca(2+)-ATPase.
    Aureliano M; Mdeira VM
    Biochim Biophys Acta; 1994 Apr; 1221(3):259-71. PubMed ID: 8167147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ion pumps as biological targets for decavanadate.
    Aureliano M; Fraqueza G; Ohlin CA
    Dalton Trans; 2013 Sep; 42(33):11770-7. PubMed ID: 23636581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The binding of vanadium (V) oligoanions to sarcoplasmic reticulum.
    Varga S; Csermely P; Martonosi A
    Eur J Biochem; 1985 Apr; 148(1):119-26. PubMed ID: 3156737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decavanadate induces mitochondrial membrane depolarization and inhibits oxygen consumption.
    Soares SS; Gutiérrez-Merino C; Aureliano M
    J Inorg Biochem; 2007 May; 101(5):789-96. PubMed ID: 17349695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, physicochemical and pharmacological characterizations of a tetra-[methylimidazolium] dihydrogen decavanadate, inhibiting the IGR39 human melanoma cells development.
    Aissa T; Aissaoui-Zid D; Moslah W; Khamessi O; Ksiksi R; Oltermann M; Ruck M; Zid MF; Srairi-Abid N
    J Inorg Biochem; 2024 Nov; 260():112672. PubMed ID: 39079338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decavanadate effects in biological systems.
    Aureliano M; Gândara RM
    J Inorg Biochem; 2005 May; 99(5):979-85. PubMed ID: 15833319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoglycemic, lipid-lowering and metabolic regulation activities of metforminium decavanadate (H2Metf)3 [V10O28]·8H2O using hypercaloric-induced carbohydrate and lipid deregulation in Wistar rats as biological model.
    Treviño S; Sánchez-Lara E; Sarmiento-Ortega VE; Sánchez-Lombardo I; Flores-Hernández JÁ; Pérez-Benítez A; Brambila-Colombres E; González-Vergara E
    J Inorg Biochem; 2015 Jun; 147():85-92. PubMed ID: 25920353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent perspectives into biochemistry of decavanadate.
    Aureliano M
    World J Biol Chem; 2011 Oct; 2(10):215-25. PubMed ID: 22031844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decavanadate Toxicology and Pharmacological Activities: V10 or V1, Both or None?
    Aureliano M
    Oxid Med Cell Longev; 2016; 2016():6103457. PubMed ID: 26904166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vanadate oligoanions interact with the proton ejection by the Ca2+ pump of sarcoplasmic reticulum.
    Aureliano M; Madeira VM
    Biochem Biophys Res Commun; 1994 Nov; 205(1):161-7. PubMed ID: 7999017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Competition between decavanadate and fluorescein isothiocyanate on the Ca2+-ATPase of sarcoplasmic reticulum.
    Csermely P; Varga S; Martonosi A
    Eur J Biochem; 1985 Aug; 150(3):455-60. PubMed ID: 3160591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Actin as a potential target for decavanadate.
    Ramos S; Moura JJ; Aureliano M
    J Inorg Biochem; 2010 Dec; 104(12):1234-9. PubMed ID: 20807665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The phenomenon of acquired resistance to metformin in breast cancer cells: The interaction of growth pathways and estrogen receptor signaling.
    Scherbakov AM; Sorokin DV; Tatarskiy VV; Prokhorov NS; Semina SE; Berstein LM; Krasil'nikov MA
    IUBMB Life; 2016 Apr; 68(4):281-92. PubMed ID: 26892736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decavanadate (V10 O28 6-) and oxovanadates: oxometalates with many biological activities.
    Aureliano M; Crans DC
    J Inorg Biochem; 2009 Apr; 103(4):536-46. PubMed ID: 19110314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decavanadate inhibits the cell-free activation of neutrophil NADPH oxidase without affecting tyrosine phosphorylation.
    Okamura N; Sakai T; Nishimura Y; Sakai M; Araki S; Yamaguchi M; Ishibashi S
    Biol Pharm Bull; 1999 Aug; 22(8):799-804. PubMed ID: 10480316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vanadate induces necrotic death in neonatal rat cardiomyocytes through mitochondrial membrane depolarization.
    Soares SS; Henao F; Aureliano M; Gutiérrez-Merino C
    Chem Res Toxicol; 2008 Mar; 21(3):607-18. PubMed ID: 18251508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vanadate oligomer inhibition of passive and active Ca2+ translocation by the Ca2+ pump of sarcoplasmic reticulum.
    Aureliano M
    J Inorg Biochem; 2000 May; 80(1-2):145-7. PubMed ID: 10885476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.